Nianhua Ding

760 total citations
17 papers, 565 citations indexed

About

Nianhua Ding is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Nianhua Ding has authored 17 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Nianhua Ding's work include Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Risks and Factors (2 papers). Nianhua Ding is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Risks and Factors (2 papers). Nianhua Ding collaborates with scholars based in China. Nianhua Ding's co-authors include Zhi Xiao, Weihua Liao, Liangrong Shi, Yibei Zhu, Yi Zhang, Wei Wu, Changli Peng, Changping Wu, Chunhui Zhou and Hongbing Shi and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Nianhua Ding

17 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianhua Ding China 11 223 202 128 105 100 17 565
Xiangyuan Luo China 11 151 0.7× 391 1.9× 127 1.0× 49 0.5× 178 1.8× 19 698
Beibei Zhai China 11 195 0.9× 276 1.4× 35 0.3× 76 0.7× 111 1.1× 24 517
Sarah Tucker Marrison United States 6 123 0.6× 276 1.4× 40 0.3× 145 1.4× 172 1.7× 10 603
Duo Zuo China 13 101 0.5× 509 2.5× 38 0.3× 103 1.0× 264 2.6× 31 767
Jiamin Cheng China 9 155 0.7× 277 1.4× 45 0.4× 34 0.3× 173 1.7× 26 498
Yang Qin China 16 120 0.5× 433 2.1× 48 0.4× 59 0.6× 227 2.3× 44 643
Jindian Li China 14 96 0.4× 136 0.7× 55 0.4× 134 1.3× 31 0.3× 33 487
Hengxing Chen China 13 120 0.5× 309 1.5× 69 0.5× 71 0.7× 149 1.5× 19 516
Peishan Hu China 16 172 0.8× 564 2.8× 98 0.8× 56 0.5× 310 3.1× 30 832
Salim Khiati France 18 145 0.7× 557 2.8× 48 0.4× 43 0.4× 72 0.7× 26 791

Countries citing papers authored by Nianhua Ding

Since Specialization
Citations

This map shows the geographic impact of Nianhua Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianhua Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianhua Ding more than expected).

Fields of papers citing papers by Nianhua Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianhua Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianhua Ding. The network helps show where Nianhua Ding may publish in the future.

Co-authorship network of co-authors of Nianhua Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Nianhua Ding. A scholar is included among the top collaborators of Nianhua Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianhua Ding. Nianhua Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ding, Nianhua, Jian Pang, Xuan Liu, et al.. (2024). Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial. Breast Cancer Research. 26(1). 9–9. 3 indexed citations
2.
Pang, Jian, et al.. (2024). Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy. Scientific Reports. 14(1). 6578–6578. 10 indexed citations
3.
Pang, Jian, Nianhua Ding, Xuan Liu, et al.. (2024). Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. Annals of Surgical Oncology. 32(2). 750–759. 37 indexed citations
4.
Hu, Huiyu, Nianhua Ding, Haiyan Zhou, et al.. (2021). A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report. Journal of Medical Case Reports. 15(1). 277–277. 2 indexed citations
5.
6.
Yuan, Jiaqi, Nianhua Ding, & Zhi Xiao. (2020). The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients. Frontiers in Pharmacology. 11. 537265–537265. 10 indexed citations
7.
8.
9.
Shi, Liangrong, Junjun Wang, Nianhua Ding, et al.. (2019). Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nature Communications. 10(1). 5421–5421. 203 indexed citations
10.
Ding, Nianhua, et al.. (2019). Prognostic Factors for Luminal B-like Breast Cancer. Current Medical Science. 39(3). 396–402. 10 indexed citations
11.
Ding, Nianhua, Jiaqi Yuan, Jie Mao, et al.. (2019). Yes-associated protein expression in paired primary and local recurrent breast cancer and its clinical significance. Current Problems in Cancer. 43(5). 429–437. 9 indexed citations
12.
Jiang, He, Jianhua Zhou, Zhi Xiao, et al.. (2019). EIF2A promotes cell survival during paclitaxel treatment in vitro and in vivo. Journal of Cellular and Molecular Medicine. 23(9). 6060–6071. 42 indexed citations
13.
Ding, Nianhua, Lu Zhang, Zhi Xiao, et al.. (2018). NEK4 kinase regulates EMT to promote lung cancer metastasis. Journal of Cellular and Molecular Medicine. 22(12). 5877–5887. 27 indexed citations
14.
Bi, Anyao, Gao Tang, Xiaozheng Cao, et al.. (2017). A novel naphthalimide-based probe for ultrafast, highly selective and sensitive detection of formaldehyde. Sensors and Actuators B Chemical. 255. 3292–3297. 61 indexed citations
15.
Wang, Xiangbo, Lu Zhang, Nianhua Ding, et al.. (2015). Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation. Biochemical and Biophysical Research Communications. 461(2). 329–333. 13 indexed citations
16.
Zhang, Lu, Bowen Xie, Xinhui Yang, et al.. (2015). FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition. Cancer Letters. 363(2). 137–145. 71 indexed citations
17.
Xiao, Zhi, Nianhua Ding, Guiqing Xiao, et al.. (2012). Reversal of Multidrug Resistance by Gefitinib Via RAF1/ERK Pathway in Pancreatic Cancer Cell Line. The Anatomical Record. 295(12). 2122–2128. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangyuan Luo Breakdown of academic impact, for papers by Beibei Zhai Breakdown of academic impact, for papers by Sarah Tucker Marrison Breakdown of academic impact, for papers by Duo Zuo Breakdown of academic impact, for papers by Jiamin Cheng Breakdown of academic impact, for papers by Yang Qin Breakdown of academic impact, for papers by Jindian Li Breakdown of academic impact, for papers by Hengxing Chen Breakdown of academic impact, for papers by Peishan Hu Breakdown of academic impact, for papers by Salim Khiati
Rankless by CCL
2026